India
· Delayed Price · Currency is INR Ajooni Biotech Statistics
Total Valuation
Ajooni Biotech has a market cap or net worth of INR 1.46 billion. The enterprise value is 1.26 billion.
| Market Cap | 1.46B |
| Enterprise Value | 1.26B |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Ajooni Biotech has 172.24 million shares outstanding. The number of shares has increased by 593.01% in one year.
| Shares Outstanding | 172.24M |
| Shares Change (YoY) | +593.01% |
| Shares Change (QoQ) | +70.60% |
| Owned by Insiders (%) | 15.77% |
| Owned by Institutions (%) | n/a |
| Float | 144.17M |
Valuation Ratios
The trailing PE ratio is 45.94.
| PE Ratio | 45.94 |
| Forward PE | n/a |
| PS Ratio | 1.21 |
| PB Ratio | 1.54 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 56.57 |
| EV / Sales | 1.49 |
| EV / EBITDA | 50.71 |
| EV / EBIT | 76.68 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.85, with a Debt / Equity ratio of 2.42.
| Current Ratio | 11.85 |
| Quick Ratio | 6.81 |
| Debt / Equity | 2.42 |
| Debt / EBITDA | 0.83 |
| Debt / FCF | n/a |
| Interest Coverage | 2.87 |
Financial Efficiency
Return on equity (ROE) is 3.54% and return on invested capital (ROIC) is 1.50%.
| Return on Equity (ROE) | 3.54% |
| Return on Assets (ROA) | 1.39% |
| Return on Capital (ROIC) | 1.50% |
| Revenue Per Employee | 7.78M |
| Profits Per Employee | 204,358 |
| Employee Count | 109 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 5.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +106.10% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +106.10% |
| 50-Day Moving Average | 8.02 |
| 200-Day Moving Average | 6.31 |
| Relative Strength Index (RSI) | 47.69 |
| Average Volume (20 Days) | 2,393,990 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ajooni Biotech had revenue of INR 847.70 million and earned 22.28 million in profits. Earnings per share was 0.18.
| Revenue | 847.70M |
| Gross Profit | 107.87M |
| Operating Income | 16.43M |
| Pretax Income | 32.28M |
| Net Income | 22.28M |
| EBITDA | 24.85M |
| EBIT | 16.43M |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 216.04 million in cash and 20.68 million in debt, giving a net cash position of 195.36 million or 1.13 per share.
| Cash & Cash Equivalents | 216.04M |
| Total Debt | 20.68M |
| Net Cash | 195.36M |
| Net Cash Per Share | 1.13 |
| Equity (Book Value) | 854.96M |
| Book Value Per Share | 5.48 |
| Working Capital | 720.22M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 12.72%, with operating and profit margins of 1.94% and 2.63%.
| Gross Margin | 12.72% |
| Operating Margin | 1.94% |
| Pretax Margin | 3.81% |
| Profit Margin | 2.63% |
| EBITDA Margin | 2.93% |
| EBIT Margin | 1.94% |
| FCF Margin | n/a |
Dividends & Yields
Ajooni Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -593.01% |
| Shareholder Yield | -593.01% |
| Earnings Yield | 2.18% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on October 7, 2022. It was a forward split with a ratio of 5.
| Last Split Date | Oct 7, 2022 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |